Investors Research Corp’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Investors Research Corp’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$17	–	1140
2023 Q1	$17	Buy	100 +78	+355%	+$43	﹤0.01%	1118
2022 Q4	$9	Hold	22	–	–	﹤0.01%	1138
2022 Q3	$0	Hold	22	–	–	﹤0.01%	1161
2022 Q2	$0	Hold	22	–	–	﹤0.01%	1182
2022 Q1	$0	Hold	22	–	–	﹤0.01%	1117
2021 Q4	$0	Hold	22	–	–	﹤0.01%	1070
2021 Q3	$0	Hold	22	–	–	﹤0.01%	1052
2021 Q2	$0	Buy	+22	New	+$423	﹤0.01%	1033

Investors Research Corp's CDAK Position: Q2 2023 in Review

Investors Research Corp sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 100 shares — an estimated $17 sold.

Investors Research Corp first reported a position in CDAK in Q2 2021 and held it in 8 quarters. The position peaked at $17 in Q1 2023. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Investors Research Corp reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Investors Research Corp sold 100 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $17.
Investors Research Corp first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Investors Research Corp's Codiak BioSciences, Inc. Common Stock position peaked at $17 in Q1 2023.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Investors Research Corp's 13F filing for Q2 2023, filed 14 Aug 2023.